Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 258 results found. Search for [ Lancet ]

Results 1 to 21 of 258
PB Jayakumar
April 14, 2021
The company has got permission from the Drug Controller General of India (DCGI) to import the vaccine. Reddy's is also going to tap domestically contract manufactured vaccines as and when companies are allowed to start commercial manufacturing in India


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


Reuters
April 10, 2021
A follow-up study of 33 people who received Moderna Inc's COVID-19 vaccine in early trials show the antibodies it induced are still present six months after the second dose


Reuters
April 9, 2021
I'm not telling people that they shouldn't book some holidays now, it's the first time I've been able to say that for many months, I think everybody doing it understands there are risks with coronavirus, Shapps told Sky News


BusinessToday.In
April 9, 2021
Coronavirus in India: When is COVID-19 second wave expected to end in India? IIT Kanpur scientist predicts


BusinessToday.In
April 8, 2021
Nomura said RBI's latest monetary policy stance is \"less dovish than meets the eye\" as it maintained GDP projection despite 2nd wave, projected CPI inflation higher and shifted view on forwarding guidance


BusinessToday.In
April 8, 2021
According to new findings, published in the Lancet Psychiatry journal on April 6, 34% of COVID-19 survivors were diagnosed with psychological or neurological conditions within six months of their infection


Reuters
April 7, 2021
Our results indicate that brain diseases and psychiatric disorders are more common after Covid-19 than after flu or other respiratory infections, said Max Taquet, a psychiatrist at Britain's Oxford University, who co-led the work


BusinessToday.In
April 6, 2021
Adar says Covishield has found an excellent response below the age of 50 with one dose. About 70 per cent of people are fully protected with one dose, but the second dose is necessary for long-term immunity protection, he adds


BusinessToday.In
April 6, 2021
Share of the pharma firm rose 19.99% to Rs 220.85 against previous close of Rs 184.40 on BSE. The stock opened with a gain of 15.68% at Rs 212.90


BusinessToday.In
April 5, 2021
Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.


PTI
March 29, 2021
Deepak Sapra, Dr Reddy's CEO, APIs and Services, said the data on trials is currently with the Indian regulator and the company expects it to get approved in the next few weeks


BusinessToday.In
March 24, 2021
Already the Russian Direct Investment Fund, the force behind the Russian vaccine, has signed deals with several Indian companies for the production and distribution of Sputnik V


Associated Press
March 24, 2021
Dmitry Peskov said the president would get the vaccine out of the public eye because when it comes to getting vaccinated on camera, he has never supported that, he doesn't like that


Joe C Mathew
March 22, 2021
Virchow is the fifth Indian company to have an agreement with RDIF on Sputnik V. Dr Reddy's Laboratories was the first to announce a tie-up with RDIF to conduct the bridge studies (clinical trials) of Sputnik V vaccine


Joe C Mathew
March 20, 2021
In a paper published by Nutrition, an international medical journal focusing on nutrition science, the researchers said the exploratory study demonstrates that selenium status is lower in patients with COVID-19 than in healthy controls


Reuters
March 18, 2021
India imports more than 80 per cent of its oil needs, a significant amount of which comes from West Asia


BusinessToday.In
March 18, 2021
An individual will have to shell out up to Rs 5,000 for renewing the registration of his more than a 15-year-old car. For two-wheelers, the charges of renewal and registration would be Rs 1,000 compared to the current fee of Rs 300


BusinessToday.In
March 18, 2021
Whilst prior infection in people under the age of 65 gave them around 80% protection against reinfection, those aged 65 and older were conferred only 47% protection, demonstrating that they are more likely to catch coronavirus again


BusinessToday.In
March 16, 2021
Share of Gland Pharma touched an all-time high of Rs 2,784.45, rising 9.54% against previous close of Rs 2,541 on BSE


PAGES 1 OF 13  12345